The HHS wants to move oversight of the controversial drug discount program to the CMS, which has a more aggressive history ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs ...

Hospitals could be on the hook for significantly higher outpatient drug prices. Because of the cuts to Medicaid, hospitals in the 340B program will see fewer Medicaid patients and may risk losing ...

340B was created to help serve patients with limited options, but today it rewards scale and billing volume. Congress and federal regulators must realign the provision with its original purpose.

For 340B Health’s Testoni, the decision is “a clear message that HRSA has not been transparent or consistent in its interpretation of 340B. ...

Second, the 340B program creates adverse incentives that increase overall healthcare costs and decrease patient choice. For instance, independent doctor’s practices do not qualify for 340B status.

There are several ways the 340B program negatively impacts employers, according to Gremminger. One is that when a drug is filled through the 340B channel instead of through the employers’ PBM ...

Abbye E. Alexander, Christopher J. Tellner and Talya Van Embden of Kaufman Dolowich discuss litigation over the 340B Drug Pricing Program, intended to help health care providers serve financially ...

Written in response to Rep. Waxman’s article on 340B published in December 2022 on Forefront. The author argues, “the 340B program has become gamed by large corporations to increase revenue.